Meeting Report of the Fifth International Cancer Epigenetics Conference in Beijing, China, October 2016-Reference-Cited by-同舟云学术

Meeting Report of the Fifth International Cancer Epigenetics Conference in Beijing, China, October 2016

Published:2017-07 Issue:7 Volume:9 Page:937-941
ISSN:1750-1911
Container-title:Epigenomics
language:en
Short-container-title:Epigenomics

Author:

Gao Dan¹²,Herman James G³,Cui Hengmi⁴,Jen Jin⁵,Fuks Francois⁶,Brock Malcolm V⁷,Ushijima Toshikazu⁸,Croce Carlo⁹,Akiyama Yoshimitsu¹⁰,Guo Mingzhou¹

Affiliation:

1. Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing 100853, China

2. School of Medicine, Nankai University, Tianjin 300071, China

3. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburg, PA 15232, USA

4. Institute of Epigenetics & Epigenomics, Yangzhou University, Yangzhou 225000, China

5. Department of Laboratory of Medicine & Pathology, Mayo Clinic, Rochester, MN 55905, USA

6. Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels 1070, Belgium

7. Oncology Center, Johns Hopkins University, Baltimore, MD 21231, USA

8. Division of Epigenomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan

9. Department of Cancer Biology & Genetics, College of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA

10. Department of Molecular Oncology, Graduate School of Medical & Dental Sciences, Tokyo Medical & Dental University, Tokyo 113-8519, Japan

Abstract

Fifth International Cancer Epigenetics Conference, Beijing, China, 21–23 October 2016 This meeting reported many new findings in the field of cancer epigenetics, including basic science, translational and clinical studies. In this report, we summarize some of the main advancements and prospects in cancer epigenetics presented at this meeting.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Genetics

Link

https://www.futuremedicine.com/doi/pdf/10.2217/epi-2017-0030

Reference18 articles.

1. Hypomethylation distinguishes genes of some human cancers from their normal counterparts

2. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

3. Epigenetics of Colorectal Cancer

4. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

5. Mutation inTET2in Myeloid Cancers